Updated August 18, 2021
The original link broke.
You can still read about the same topic here:
--- the original post follows below ---
- Slowing Growth in Mature Markets
- Rapid Expansion of “Pharmerging” Markets
- An Emphasis on Specialist-Driven Markets
- Fewer Products Winning Regulatory Approval
- An Economic Slowdown, Most Pronounced in the US
- Generics Market Continues to Evolve
- Intensified Involvement of Payers and Health Technology Assessors
Return Home: http://drughealth.blogspot.com/
The Health, Drug, Prescription, and GMP Supersite Gift Store
Posts
No comments:
Post a Comment